<?xml version="1.0" encoding="UTF-8"?>
<p>The World Health Organization states that the annual number of deaths due to sepsis worldwide is approximately 6 million, most of which are preventable.
 <xref rid="cit0005" ref-type="bibr">5</xref> The identification of altered molecular signatures and biochemical pathways in sepsis patients has driven interest in the discovery of novel biomarkers.
 <xref rid="cit0006" ref-type="bibr">6</xref> Early recognition of sepsis is essential for timely treatment and can improve sepsis outcomes.
 <xref rid="cit0007" ref-type="bibr">7</xref>,
 <xref rid="cit0008" ref-type="bibr">8</xref> Mortality risk is higher when sepsis treatment is delayed.
 <xref rid="cit0009" ref-type="bibr">9</xref> Analyzing the molecular characteristics of patients is an effective method to screen for potential diagnostic and prognostic targets.
 <xref rid="cit0010" ref-type="bibr">10</xref>
</p>
